Creatine HCl
Compiled from published pharmacological and botanical literature. Not independently verified by Herbuno. Spotted an error or have a correction? Flag it below →
| Compound | Creatine monohydrochloride |
|---|---|
| Chemical class | Hydrochloride salt of creatine (methylguanidinoacetic acid) |
| CAS | 17050-09-8 (creatine HCl) · 6020-87-7 (creatine monohydrate) |
| Molecular weight | 167.59 g/mol (creatine free base 131.13) |
| Free base equivalence | 78.2% creatine · monohydrate delivers 87.9% |
| Solution pH | Approx. 1.0–1.5 at 10% — strongly acidic |
| Claim strength | High for solubility; the equivalent-at-lower-dose claim is unsupported |
| Buy from Herbuno | Creatine HCl 99% Powder · Creatine Monohydrate 200/80 Mesh Powder |
| Origin | Processed / Sourced from India |
| MOQ | R&D 100 g / 250 g (subject to stock) · Pilot batch 1–5 kg · Bulk 10 kg, 25 kg and above |
| Lead Time | Dispatch within 72 hrs from stock · fresh-batch production (typically 50 kg+): 10 working days |
| Documentation | CoA & MSDS standard with every lot |
Name origin: Creatine takes its name from the Greek kreas, flesh, reflecting Michel Chevreul's 1832 isolation of it from skeletal muscle. The hydrochloride is a comparatively recent commercial form, introduced in the late 2000s and patented as a creatine salt with substantially higher aqueous solubility than the monohydrate. It is formed by adding one equivalent of hydrochloric acid across creatine's guanidinium group.
Why the salt exists: Creatine monohydrate is poorly soluble — around 14 grams per litre at room temperature — which means a 5 gram dose does not fully dissolve in a typical serving of water and leaves a gritty residue. That is a real and persistent consumer complaint, and the principal commercial motivation for every alternative creatine form. The hydrochloride is dramatically more soluble, by most reported measures by more than an order of magnitude, and gives clear solutions. That advantage is genuine and measurable.
Research trajectory: Creatine monohydrate has one of the largest and most consistent evidence bases of any sports nutrition ingredient, spanning hundreds of controlled trials on strength, power output, lean mass and, increasingly, cognition. Creatine HCl has very little independent clinical literature. The few comparative studies that exist are small and have generally examined solubility, plasma kinetics or tolerability rather than performance outcomes, and none has established superior efficacy. This asymmetry is the central fact about the form.
Commercial source: Creatine, in both forms, is produced by chemical synthesis rather than extraction, typically from sarcosine and cyanamide, with the hydrochloride formed by acidification and crystallisation. The relevant process impurities — principally dicyandiamide and dihydrotriazine, with creatinine as the degradation product — are identical in kind to those of the monohydrate and must be specified in the same way.
Evidence for Creatine HCl Applications
The solubility advantage is real, large and the one claim that holds without qualification. Creatine monohydrate dissolves at roughly 14 grams per litre at room temperature, which is why a 5 gram dose in 250 millilitres leaves undissolved material. Creatine HCl is more soluble by more than an order of magnitude on most reported measures and gives clear solutions at practical concentrations. For ready-to-drink formats, concentrated shots, clear beverages and any application where visible sediment is unacceptable, this is a decisive and legitimate formulation advantage. Claim strength: High.
The claim that higher solubility permits a lower effective dose is not supported and should not be made. The marketing argument runs that superior solubility implies superior absorption, therefore a fraction of the monohydrate dose suffices. Solubility and bioavailability are not the same property, and creatine monohydrate's oral bioavailability is already close to complete — it is one of the better-absorbed supplement ingredients, so there is little headroom for a more soluble form to improve on. No controlled trial has demonstrated equivalent muscle creatine saturation or performance outcomes from a reduced dose of the hydrochloride. Claim strength: High that the claim is unsupported.
On a per-gram basis the hydrochloride delivers less creatine than the monohydrate, which runs against the lower-dose narrative. Creatine HCl at 167.59 g/mol delivers 78.2% creatine; creatine monohydrate at 149.15 g/mol delivers 87.9%. So 1 gram of monohydrate provides 879 milligrams of creatine against the hydrochloride's 782, and matching a 5 gram monohydrate dose requires 5.62 grams of the hydrochloride. Any dose comparison between the forms has to be made on creatine content, and doing so removes rather than supports the case for a smaller serving. Claim strength: High.
Tolerability is the second defensible argument for the form, and it is plausible rather than demonstrated. A proportion of users report bloating or gastrointestinal discomfort with monohydrate, generally attributed to undissolved material and osmotic effects in the gut. A fully dissolved dose would reasonably be expected to reduce that, and the mechanism is coherent. Controlled comparative tolerability data are limited, so this is a reasonable formulation rationale rather than an evidenced claim, and it should be stated as such. Claim strength: Emerging.
Creatine's underlying evidence base belongs to the monohydrate and should not be transferred silently. The hundreds of trials establishing creatine's effects on strength, power, lean mass and more recently cognition were conducted overwhelmingly with monohydrate, which is also the form named in the EFSA authorised health claim and in most regulatory and position-stand documents. A hydrochloride product citing that literature is relying on creatine the molecule, which is defensible, but should not imply the salt form was what was tested. Where a monograph or authorised claim specifies monohydrate, the hydrochloride does not qualify. Claim strength: High.
The acidity is a formulation constraint that the solubility advantage partly offsets. Creatine HCl gives strongly acidic solutions, around pH 1.0 to 1.5 at 10%, which affects the stability of co-formulated actives, contributes materially to the acid load of a reconstituted beverage, and can be harsh on dental enamel and gastric mucosa in a concentrated shot. Against that, low pH suppresses creatine's conversion to creatinine, so the hydrochloride is actually more stable in acidic solution than the monohydrate is in a neutral one — a real advantage for liquid formats with shelf life. Claim strength: Moderate.
Sourcing creatine HCl from Herbuno. We supply creatine HCl and creatine monohydrate in 200 and 80 mesh.
Our position on form selection is specific: choose the hydrochloride where solubility is the binding constraint — clear beverages, shots, ready-to-drink with shelf life — and the monohydrate everywhere else, including capsules and conventional powders, where it is cheaper, denser in creatine and carries the entire evidence base. We will not support a lower-dose equivalence claim for the hydrochloride, because no controlled trial establishes it. All lots ship with CoA and MSDS; request a quotation for pilot or bulk volumes.
Dosage & Formulator Specification
Dose on creatine content, not on salt weight. The established effective intake is 3 to 5 grams of creatine daily for maintenance, with an optional loading phase of around 20 grams daily in divided doses for five to seven days. Delivered as the hydrochloride at 78.2% creatine, a 5 gram creatine target requires 6.39 grams of salt; as monohydrate at 87.9%, it requires 5.69 grams. Stating the serving in salt weight without the creatine equivalent understates the dose against the literature, and in this category that is the most common labelling error.
The loading phase is where the hydrochloride's economics turn against it. Twenty grams of creatine daily requires 25.6 grams of hydrochloride against 22.8 grams of monohydrate, at a materially higher price per gram. For a product designed around a loading protocol the monohydrate is the rational choice; the hydrochloride's case rests on formats where loading is not the model and where dissolution quality drives the purchase. Being explicit about this with customers is better commercially than discovering it at reorder.
Handling favours the hydrochloride on solubility and disfavours it on acidity. It dissolves readily and clearly at practical concentrations, is mildly hygroscopic and should be stored sealed, and flows acceptably as a crystalline powder. Taste is sharply acidic and sour rather than the monohydrate's near-neutral blandness, so a flavour system designed around monohydrate will not transfer without rework. In a dry blend the acidity matters little; in anything that will be reconstituted or sold as a liquid, calculate the total acid load across the formula.
Liquid stability is a genuine and under-discussed advantage. Creatine degrades to creatinine in aqueous solution, and the rate is strongly pH-dependent, rising as pH approaches neutrality. The hydrochloride's intrinsic acidity places it in the pH range where creatinine formation is slowest, so a creatine HCl liquid has a meaningfully longer usable shelf life than a neutral creatine monohydrate solution. For ready-to-drink development this, rather than the dissolution cosmetics, is often the stronger technical argument. Validate creatinine on accelerated stability rather than assuming it.
For analytical control, specify creatine assay with the basis stated — salt or creatine content — chloride confirming stoichiometry, and creatinine as a limit test, since it is the degradation product and the direct indicator of material and storage quality. Specify dicyandiamide and dihydrotriazine limits: these are synthesis-related impurities common to both creatine forms, they are the recognised quality markers in this category, and they are not captured by a creatine assay. Standard coverage includes heavy metals, residual solvents, microbiological limits, loss on drying and sulphated ash.
On claim construction, the defensible framing is narrow and worth writing into customer documentation. The solubility advantage is measurable and can be stated plainly. The improved liquid stability at low pH follows from creatine chemistry and can be stated. Reduced gastrointestinal discomfort is a plausible consequence of complete dissolution and should be framed as a formulation rationale rather than a demonstrated outcome. Equivalent efficacy at a reduced dose, superior absorption, and superior muscle creatine saturation are not supported by controlled trials and should not appear. Creatine's performance evidence can be cited as creatine's, provided the documentation does not imply the hydrochloride was the tested form, and where a regulatory monograph or authorised claim names creatine monohydrate specifically, the hydrochloride does not satisfy it.
Frequently Asked Questions — Creatine HCl
Is creatine HCl better than monohydrate?
More soluble, yes — by more than an order of magnitude, which matters for clear beverages and shots. More effective, no. No controlled trial has shown superior performance outcomes or muscle creatine saturation. Monohydrate carries essentially the entire evidence base, is cheaper, and is denser in creatine per gram.
Can I use a smaller dose of creatine HCl?
No, and the arithmetic runs the other way. Solubility is not bioavailability, and monohydrate's oral absorption is already near-complete, so there is little headroom to improve on. The hydrochloride is also only 78.2% creatine against monohydrate's 87.9% — matching a 5 g monohydrate dose needs 5.62 g of hydrochloride, not less.
When is the hydrochloride the right choice?
Where solubility is the binding constraint: clear ready-to-drink, concentrated shots, any format where visible sediment is unacceptable. Also where a liquid needs shelf life — creatine degrades to creatinine fastest near neutral pH, so the hydrochloride's intrinsic acidity actually slows it. For capsules and conventional powders, monohydrate.
Why does the acidity matter?
Creatine HCl gives pH 1.0 to 1.5 at 10%. That affects co-formulated active stability, contributes materially to the acid load of a reconstituted drink, and is harsh on enamel and gastric mucosa in a concentrated shot. A flavour system built around monohydrate's near-neutral blandness will not transfer without rework.
What should I specify beyond assay?
Creatinine as a limit test — it is the degradation product and the direct indicator of material and storage quality. Dicyandiamide and dihydrotriazine limits, which are the recognised synthesis-related impurity markers for creatine in either form and are not caught by a creatine assay. Plus chloride to confirm stoichiometry.
Can I use creatine's research on a creatine HCl label?
As creatine's research, carefully. The trials were run overwhelmingly on monohydrate, which is also the form named in the EFSA authorised claim and most position stands. Citing creatine the molecule is defensible; implying the hydrochloride was the tested form is not. Where a monograph or authorised claim names monohydrate, the hydrochloride does not qualify.